Diagnosis and management of neurotrophic keratitis

Overview of attention for article published in Clinical Ophthalmology, March 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 4 news outlets
policy: 2 policy sources
twitter: 3 X users

patent: 1 patent
wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 314 Dimensions

Readers on

mendeley: 255 Mendeley

Summary News Policy documents X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

cenegermin

Cited by Canadian Agency for Drugs and Technologies in Health on 12 Sep 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Cenegermin for treating neurotrophic keratitis: Committee papers

Cited by National Institute for Health and Care Excellence on 20 Mar 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Dove Medical Press

Article Metrics